HR 4100
116th Congress
House
Health
Congressional oversight
Drug safety, medical device, and laboratory regulation
Government information and archives
Government studies and investigations
Infectious and parasitic diseases
Medicare
DISARM Act of 2019
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 31, 2019
Referred to the Subcommittee on Health.
Jul 30, 2019
Referred to the Subcommittee on Health.
Jul 30, 2019
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 30, 2019
Introduced in House
Plain-English summary
Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019 or the DISARM Act of 2019
This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4